Hello, everyone, and how are you today? We got off to a slightly late start due to our fickle laptop, but all appears well now. Of course, coping with such vagaries calls for a cup of stimulation - we are switching to Southern Pecan this morning - and invite you to join us. As always, there is much to do and we are, in fact, behind schedule this week. So no time to waste, here are some tidbits to help you along. Hope your day goes well and you accomplish much. And drop us a line if you come across something interesting...
Bayer Yasmin Settlements Rise to $403M (Bloomberg News)
HPV Vaccines Have Poor Adherence (Financial Times)
Idenix And Novartis Restructure Hepatitis C Deal (Pharma Times)
UK Reaps Patent Cliff As Medicine Bill Falls (Reuters)
Cambridge Planning Board Rejects Novartis Courtyard Proposal (The Tech)
EMA Reports Greater Interaction With Japanese Regulators (Pharma Times)
Nigeria Seals Off Drugmaker Over Cough Syrup (The Leadership)
EDITOR'S NOTE: Please check this post for updates during the day
1 Comment